Robert Kassees

759 total citations
6 papers, 162 citations indexed

About

Robert Kassees is a scholar working on Molecular Biology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Robert Kassees has authored 6 papers receiving a total of 162 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 1 paper in Genetics and 1 paper in Pulmonary and Respiratory Medicine. Recurrent topics in Robert Kassees's work include PI3K/AKT/mTOR signaling in cancer (3 papers), Glycosylation and Glycoproteins Research (1 paper) and Protein Kinase Regulation and GTPase Signaling (1 paper). Robert Kassees is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (3 papers), Glycosylation and Glycoproteins Research (1 paper) and Protein Kinase Regulation and GTPase Signaling (1 paper). Robert Kassees collaborates with scholars based in United States. Robert Kassees's co-authors include Deepak Sampath, Wayne J. Fairbrother, Jiping Zha, Nguyen Tan, Lisa D. Belmont, Leanne Berry, Yue Peng, Marcia Belvin, Kyle A. Edgar and Wei Wei Prior and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Science Translational Medicine.

In The Last Decade

Robert Kassees

6 papers receiving 151 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Kassees United States 3 127 74 25 21 20 6 162
Ben Jenkins United Kingdom 4 130 1.0× 52 0.7× 21 0.8× 19 0.9× 19 0.9× 7 172
Haoxuan Tong United States 2 113 0.9× 34 0.5× 15 0.6× 17 0.8× 17 0.8× 2 136
Sapana Thomas United States 2 112 0.9× 67 0.9× 22 0.9× 21 1.0× 15 0.8× 2 157
Marek Wanior Germany 7 251 2.0× 86 1.2× 29 1.2× 39 1.9× 31 1.6× 8 289
Trupti Lingaraj United States 8 226 1.8× 54 0.7× 31 1.2× 17 0.8× 15 0.8× 14 279
Ashleigh Parkin Australia 7 83 0.7× 66 0.9× 14 0.6× 11 0.5× 15 0.8× 7 144
Elena Armenteros-Monterroso United Kingdom 3 194 1.5× 83 1.1× 22 0.9× 11 0.5× 44 2.2× 4 237
Grace Wing-Yan Mak Hong Kong 6 128 1.0× 57 0.8× 34 1.4× 10 0.5× 12 0.6× 8 175
Sylvia M. Frydman United States 4 174 1.4× 126 1.7× 18 0.7× 21 1.0× 62 3.1× 6 237
Inchul You United States 8 305 2.4× 129 1.7× 14 0.6× 17 0.8× 32 1.6× 11 351

Countries citing papers authored by Robert Kassees

Since Specialization
Citations

This map shows the geographic impact of Robert Kassees's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Kassees with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Kassees more than expected).

Fields of papers citing papers by Robert Kassees

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Kassees. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Kassees. The network helps show where Robert Kassees may publish in the future.

Co-authorship network of co-authors of Robert Kassees

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Kassees. A scholar is included among the top collaborators of Robert Kassees based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Kassees. Robert Kassees is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Choo, Edna F., Marcia Belvin, Jason Boggs, et al.. (2012). Preclinical Disposition of GDC-0973 and Prospective and Retrospective Analysis of Human Dose and Efficacy Predictions. Drug Metabolism and Disposition. 40(5). 919–927. 28 indexed citations
2.
Nannini, Michelle, Rebecca Hong, Brian B. Lee, et al.. (2012). Abstract 873: Combined targeting of Akt and MEK with the Akt inhibitor GDC-0068 and MEK inhibitor GDC-0973 demonstrates synergistic anti-tumor effects. Cancer Research. 72(8_Supplement). 873–873. 2 indexed citations
3.
Tan, Nguyen, Jiping Zha, Yue Peng, et al.. (2011). Navitoclax Enhances the Efficacy of Taxanes in Non–Small Cell Lung Cancer Models. Clinical Cancer Research. 17(6). 1394–1404. 83 indexed citations
4.
Tan, Nguyen, Robert Kassees, Megan Berry, et al.. (2011). Abstract 3151: Navitoclax enhances the activity of chemo-therapeutic and targeted agents across a large panel of epithelial cancer cell lines. Cancer Research. 71(8_Supplement). 3151–3151. 1 indexed citations
5.
Wallin, Jeffrey J., Jane Guan, Wei Wei Prior, et al.. (2010). Nuclear Phospho-Akt Increase Predicts Synergy of PI3K Inhibition and Doxorubicin in Breast and Ovarian Cancer. Science Translational Medicine. 2(48). 48ra66–48ra66. 46 indexed citations
6.
Sampath, Deepak, Marcia Belvin, Jing Guan, et al.. (2008). 220 POSTER Combination of class I PI3K inhibitor, GDC-0941, with standard of care therapeutics results in enhanced anti-tumor responses in human cancer models in vitro and in vivo. European Journal of Cancer Supplements. 6(12). 69–70. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026